Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 4/20 | 0.36 |
| ▸ | ASIC3 | Q9UHC3 | 1/20 | 0.35 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | EGFR | P00533 | 1/20 | 0.30 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6793030 | 0.84 | ASIC3 (0.34) | OPRD1ASIC3 | |
| SCHEMBL6792836 | 0.81 | ALDH1A1 (0.38) | ALDH1A1NPC1RAB9AL3MBTL1 | |
| SCHEMBL6503516 | 0.75 | ASIC3 (0.37) | OPRD1ASIC3TSHRALDH1A1EGFR | |
| SCHEMBL8128151 | 0.72 | ALDH1A1 (0.39) | TAAR1TSHRALDH1A1KCNH2 | |
| SCHEMBL6164927 | 0.69 | GABRP (0.39) | OPRD1ASIC3NR3C2 | |
| SCHEMBL6164930 | 0.69 | GABRP (0.39) | OPRD1ASIC3NR3C2 | |
| Aniline SCHEMBL11231186 | 0.67 | ALDH1A1 (0.48) | TAAR1TSHRALDH1A1L3MBTL1 | |
| SCHEMBL22780620 | 0.67 | ASIC3 (0.46) | ASIC3TAAR1ALDH1A1NR3C2 | |
| SCHEMBL293009 | 0.65 | ASIC3 (0.41) | ASIC3TSHRALDH1A1NPC1RAB9A | |
| SCHEMBL27582427 | 0.64 | ALDH1A1 (0.42) | OPRD1TSHRALDH1A1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040058903-A1 | Benzamide compounds as apo b secretion inhibitors | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040058903-A1 | Benzamide compounds as apo b secretion inhibitors | APOB, APOL1, SCARB1 | OPRD1 288/4885ASIC3 3567/4885TAAR1 1091/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.